000 01478 a2200445 4500
005 20250513190957.0
264 0 _c19990928
008 199909s 0 0 eng d
022 _a0017-5749
024 7 _a10.1136/gut.45.3.382
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHearing, S D
245 0 0 _aPredicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes.
_h[electronic resource]
260 _bGut
_cSep 1999
300 _a382-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aColitis, Ulcerative
_xdrug therapy
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Resistance
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGlucocorticoids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aT-Lymphocytes
_xdrug effects
650 0 4 _aTreatment Failure
650 0 4 _aTreatment Outcome
700 1 _aNorman, M
700 1 _aProbert, C S
700 1 _aHaslam, N
700 1 _aDayan, C M
773 0 _tGut
_gvol. 45
_gno. 3
_gp. 382-8
856 4 0 _uhttps://doi.org/10.1136/gut.45.3.382
_zAvailable from publisher's website
999 _c10403828
_d10403828